Literature DB >> 16146377

Efforts toward the total synthesis of (-)-kendomycin.

David R Williams1, Khalida Shamim.   

Abstract

[structure: see text] The synthesis of an advanced component leading to (-)-kendomycin is described. The synthetic scheme features the application of asymmetric conjugate addition methodology for the early generation of the C13-C14 (E)-trisubstituted olefin, providing an efficient assembly of the ansa chain. Condensation reactions probe two strategies for attachment of the aromatic system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16146377     DOI: 10.1021/ol051512r

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  5 in total

1.  New synthetic strategies for the stereocontrolled synthesis of substituted "skipped" diepoxides.

Authors:  Christopher J Morten; Timothy F Jamison
Journal:  Tetrahedron       Date:  2009-08-15       Impact factor: 2.457

2.  Total synthesis of (+)-pilosinine via a stereodivergent conjugate addition strategy.

Authors:  Cassandra L Schrank; Michael W Danneman; Emily A Prebihalo; Robert E Anderson; Tyler J Gibson; William M Wuest; Richard J Mullins
Journal:  Tetrahedron Lett       Date:  2020-04-18       Impact factor: 2.415

Review 3.  Strategies for construction of the all-carbon macrocyclic skeleton of the ansamycin antibiotic-kendomycin.

Authors:  Shu Xu; Hirokazu Arimoto
Journal:  J Antibiot (Tokyo)       Date:  2016-02-10       Impact factor: 2.649

4.  Formal synthesis of (-)-kendomycin featuring a Prins-cyclization to construct the macrocycle.

Authors:  Kevin B Bahnck; Scott D Rychnovsky
Journal:  J Am Chem Soc       Date:  2008-09-04       Impact factor: 15.419

5.  Investigations to the Antibacterial Mechanism of Action of Kendomycin.

Authors:  Yasser A Elnakady; Indranil Chatterjee; Markus Bischoff; Manfred Rohde; Michaele Josten; Hans-Georg Sahl; Mathias Herrmann; Rolf Müller
Journal:  PLoS One       Date:  2016-01-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.